ESR1 and breast cancer: To determine the involvement of ER-α36 in the antiestrogen signaling of these breast cancer cells, we tested antiestrogen signaling in the cell lines derived from MDA-MB-231 and MDA-MB-436 that carrying knocked-down levels of ER-(36 expression by the shRNA method.